Methylnaltrexone bromide (MNTX)

DRUG2 trials

Sponsors

Beth Israel Medical Center, Bausch Health Americas, Inc.

Conditions

Colonic InertiaPancreatic Cancer

Phase 3

An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

WithdrawnNCT04151719

Bausch Health Americas, Inc.Pancreatic Cancer

Start: 2020-02-03End: 2024-02-03Updated: 2021-05-07

Phase 4

Can Methylnaltrexone Safely Treat Opioid Related Constipation in the Emergency Department?

WithdrawnNCT00949377

Beth Israel Medical CenterColonic Inertia

Start: 2009-09-30End: 2011-12-31Updated: 2015-10-14